Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 1.15Sales per Share
VS
Market
Sector
Industry
History
$ 8.3Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information
Ticker
GYRECompany Name
GYRE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGYRE THERAPEUTICS INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GYRE - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 102.19M | 1 | 89.12M | $ 1.15 |
| 3/31/2025 | $ 100.64M | 1 | 86.42M | $ 1.16 |
| 12/31/2024 | $ 105.76M | 1 | 85.09M | $ 1.24 |
| 9/30/2024 | $ 191.34M | 1 | 85.64M | $ 2.23 |
| 6/30/2024 | $ 165.85M | 1 | 85.5M | $ 1.94 |
| 3/31/2024 | $ 140.62M | 1 | 83.27M | $ 1.69 |
| 12/31/2023 | $ 113.45M | 1 | 65.83M | $ 1.72 |
| 9/30/2023 | $ 0 | 1 | 2.53M | $ 0 |
| 6/30/2023 | $ 0 | 1 | 2.52M | $ 0 |
| 3/31/2023 | $ 0 | 1 | 2.52M | $ 0 |
Key Performance Insights, Last 5 Years
- GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) SPS stands at $ 12.86.
- Over the past 5 years, GYRE THERAPEUTICS INC's average SPS has been $ 3.04.
- The median SPS for GYRE THERAPEUTICS INC during this period was $ 1.83
- GYRE THERAPEUTICS INC reached its highest SPS over the past 5 years at $ 16.38.
- The lowest SPS recorded by GYRE THERAPEUTICS INC in the same timeframe $ 0
GYRE THERAPEUTICS INC's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for GYRE THERAPEUTICS INC is calculated as follows: Revenues [ $ 18.92M ] / (Shares WA [ 1.47M ] * Share Factor [ 1 ])
(=) SPS [ $ 12.86 ] GYRE - Sales per Share, Last 5 years
$ 0
Minimum
Mar 31, 2023
$ 16.38
Maximum
Dec 31, 2020
$ 3.04
Average
$ 1.83
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.53 with a standard deviation of $ 13.59.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.64K |
|---|---|
| min | $ -18.02 |
| max | $ 54.75 |
| average | $ 11.53 |
| median | $ 5.88 |
| std | $ 13.59 |